Moscow, Russia (February 15, 2011) —Cromos Pharma, LLC—announced today that it was joining forces with two other Russian companies in creating a strategic alliance – 3C Alliance, that will provide unprecedented scope of services on the Russian clinical trials market.
Cromos Pharma, LLC – a full service CRO with operations in Russia and in Ukraine, Clinical Trial Support, LLC – service provider in customs clearance, study equipment leasing, study legal support, patient transfers and clinical trial translation, and Clinical Research Solutions, LLC – a local depot and courier service, specializing in clinical trials rescue, have formed an alliance that they called 3C Alliance. The purpose of 3C Alliance is to provide an all-inclusive service to pharmaceutical companies and CROs operating on the Russian market.
“The Alliance will make running clinical trials in Russia a totally different experience. This is the first one-stop-shop that will address all of Sponsor’s needs, starting from regulatory approvals and clinical trial monitoring and continuing with logistical support of importation of study materials, warehousing and distribution,” said Dr. Vladimir Bogin, CEO of Cromos Pharma, LLC. “It is not always easy to navigate in the Russian landscape and you need a reliable partner that is capable of addressing every aspect of a clinical trial rescue,” continued Dr. Bogin.
3C Alliance will offer its clients a unified electronic system that will give a real time assessment of all aspects of trial’s status. There will also be a single trial coordinator responsible for all trial-related needs.
Clinical trial rescue
Ukraine, the eight largest European country by population, is an attractive location for sponsors conducting clinical research for a number of key reasons. Cromos Pharma has been successfully managing clinical trials in Ukraine since 2006. This article looks at just some of the benefits of locating your next study here.
Cromos Pharma is continuously developing and looking to explore new territories when it comes to clinical research. In line with this spirit of discovery, we will be shortly commencing a new project in Uzbekistan supporting a study being conducted by the Swiss Tropical and Public Health Institute.
Cromos Pharma is delighted to be taking part in the upcoming DIA Europe conference (15 – 19 March 2021) and BIO-Europe Spring (22-25 March 2021).
February 11th is International Women and Girls in Science Day. A joint UNESCO and UN-Women initiative, it aims to promote the role of #WomenInScience and to challenge some of the barriers to girls pursuing a career in science.
Are you a sponsor seeking to conduct clinical trials in the European Union but do not have a registered office in the European Economic Area? If so, in order to comply with the European Union Clinical Trial Directive, you are required to work with a Legal Representative registered in an EEA country.
Each 4th February, #WorldCancerDay aims to raise awareness of the global personal, social and economic burden of cancer. World Cancer Day was established in Paris at the first World Cancer Summit in 2000.
As 2021 begins, many countries are grappling with a renewed surge of COVID-19 infections necessitating further public health restrictions putting more pressure on health systems, societies and global economies. The task of rolling out approved vaccines is increasingly urgent. Almost 16 million doses of COVID-19 vaccines have been administered to date in 37 countries worldwide according to data compiled by Bloomberg ( updated 7 Jan 2021).
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.